About Springboard Health Angels
Springboard Health Angels, established in 2022, is an angel investment group based in Berlin, Germany. It primarily focuses on Seed investments in companies in Germany. Its portfolio includes 8 firms, spanning the Life Sciences, Enterprise Applications sectors. Its most notable investments include companies like Captain T Cell, Virtonomy and Cellbyte. Its latest investment was a $2.75M Seed round in Cellbyte on Nov 19, 2025, which also saw participation from Frontline Ventures and Y Combinator.
To date, 25 investors have co-invested in Springboard Health Angels's portfolio companies, including prominent names like Pace Ventures.
Key Metrics
Founded Year
2022
Location
Berlin, Germany
Portfolio Companies
Sectors of Investment
Stages of Investment
Seed & Series A
Locations of Investment
Springboard Health Angels' List of Top Investments
Springboard Health Angels has a portfolio of 8 companies. Their most notable investments are in Recovery Cat and Captain T Cell.Their portfolio spans across Germany and Switzerland. They have invested in Life Sciences, Enterprise Applications, HealthTech and 3 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Springboard Health Angels:Developer of T-cell therapies against solid tumors. The company has a novel allogeneic platform to enable off-the-shelf treatments of solid tumors.
Key facts about Captain T Cell
- Founded Year: 2020
- Location: Berlin (Germany)
- Stage: Series A
- Total Funding till date: $32.5M
- Investors: Brandenburg Capital, CFH Management and 4 Others
- Latest Funding Round: Series A, Nov 17, 2025, $*****
- Highlight: Editors' Pick

2. Virtonomy
Provider of virtual patient simulation for medical device development. It offers an end-to-end digital twin and simulation solution based on real clinical data. This allows medical device developers to perform development and testing in a virtual environment, accelerating development, reducing risks and expenses, and lessening regulatory burden. The platform supports the full product life cycle, from concept to regulatory reporting. Simulations include anatomical variability, demographic diversity, and pathological conditions, enabling accurate 3D measurements and advanced statistical shape models. The platform also provides regulatory services and consultation, assisting with the creation of virtual testing plans and compliance with regulatory bodies. Virtual patient data can be used as digital evidence for regulatory submissions.
Key facts about Virtonomy
- Founded Year: 2019
- Location: Munich (Germany)
- Stage: Series A
- Total Funding till date: $9.69M
- Employee Count: 23 as on Aug 31, 2026
- Investors: Dieter von Holtzbrinck Ventures, Startup Autobahn and 12 Others
- Latest Funding Round: Series A, Dec 15, 2025, $*****
- Highlight: Editors' Pick
3. Cellbyte
AI-driven analytics platform that enables pricing and market access professionals in the pharmaceutical industry. It leverages natural language processing that enables users to extract insights from vast amounts of pharmaceutical data, streamlining the process of launching new drugs.
Key facts about Cellbyte
- Founded Year: 2024
- Location: Munich (Germany)
- Stage: Seed
- Total Funding till date: $3.25M
- Employee Count: 10 as on Mar 31, 2026
- Investors: Frontline Ventures, Y Combinator and 3 Others
- Latest Funding Round: Seed, Nov 19, 2025, $*****

4. Vivalyx
Developer of organ preservation solutions for use in labs. The company offer solutions like Vivalyx Omnisol a blood-free preservation solution for all organ preservation methods, including cold and warm perfusion as well as static cold storage, with expected beneficial clinical outcomes.
Key facts about Vivalyx
- Founded Year: 2022
- Location: Aachen (Germany)
- Stage: Seed
- Total Funding till date: $5.79M
- Employee Count: 20 as on Aug 31, 2026
- Investors: GOOSE Capital, Brightlands Venture Partners and 7 Others
- Latest Funding Round: Seed, Apr 30, 2024, $*****
- Highlight: Editors' Pick
5. Qnomx
Provider of AI-powered genomic data interpretation platform. This platform automates the interpretation of complex genomic reports, transforming them into concise clinical summaries. It streamlines the process for clinical laboratories, bioinformatics companies, and oncology clinics, reducing manual effort and accelerating turnaround times. The platform uses proprietary AI models trained on extensive clinical data sources to ensure accurate and clinically relevant results, supporting faster and more informed treatment decisions. The system integrates seamlessly with existing lab workflows, requiring minimal disruption.
Key facts about Qnomx
- Founded Year: 2024
- Location: Basel (Switzerland)
- Stage: Seed
- Total Funding till date: $1.93M
- Investors: better ventures, Springboard Health Angels and 5 Others
- Latest Funding Round: Seed, Apr 14, 2025, $*****
Springboard Health Angels' Year-on-Year Investment Trends
Springboard Health Angels has invested in 8 companies over the last 4 years, with an average of 2 new investments annually in the last 3 years. In 2025, it made 4 investments. Its most recent first time investment was in Cellbyte.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 4 | 0 | 4 |
2024 | 1 | 0 | 1 |
2023 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
Springboard Health Angels' Investments by Stage
Springboard Health Angels has made 7 investments in Seed stage with an average round size of $2.97M and 1 investment in Series A stage with an average round size of $23.2M.Stage of entry | No. of Investments |
|---|---|
Seed | 7 |
Series A | 1 |
Note: We have considered here, only first round of investments
Springboard Health Angels' Investments by Sector
Springboard Health Angels has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Life Sciences, Healthcare and Artificial Intelligence - Industry Applications. Notably, it has invested in 7 Tech companies, 6 Enterprise (B2B) companies, 5 Software companies and at least 1 company focusing on AI-Native.Sector | No. of Investments |
|---|---|
HealthTech | 5 |
Enterprise Applications | 4 |
Life Sciences | 3 |
Healthcare | 2 |
Artificial Intelligence - Industry Applications | 1 |
Others | 4 |
Note: We have considered here, only first round of investments
Springboard Health Angels' Investments by Geography
Springboard Health Angels has made most investments in Germany (5), followed by Switzerland where it has made 3 investments.Country | No. of Investments |
|---|---|
Germany | 5 |
Switzerland | 3 |
Note: We have considered here, only first round of investments
Springboard Health Angels' recent investments
Springboard Health Angels has not made any investment in 2026 so far.Here are the most recent investments by Springboard Health Angels:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Nov 19, 2025 | Germany | Seed | 8630 | [+3] | |
Nov 17, 2025 | Germany | Series A | 9963 | [+4] | |
Apr 14, 2025 | Switzerland | Seed | 7006 | [+5] | |
Apr 14, 2025 | Switzerland | Seed | 1540 | ||
Apr 30, 2024 | Germany | Seed | 4906 | [+5] |
Team profile of Springboard Health Angels
Springboard Health Angels has a team of 19 members including 3 Partners and 5 Principals located in Germany and United Kingdom. Springboard Health Angels' team does not sit on the board of any company as of now.Here is a list of top team members in Springboard Health Angels:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Berlin | - | - | |
Partner | Munich | - | - | |
Partner | Berlin | - | - | |
Principal | United Kingdom | - | - | |
Principal | Munich | - | - | |
Principal | Hamburg | - | - | |
Principal | Cologne | - | - | |
Principal | Munich | - | - |
Co-investors of Springboard Health Angels
Over the past 4 years, 41 investors have co-invested in Springboard Health Angels's portfolio companies. This includes funds and angels.
- Invested before Springboard Health Angels: i&i Bio, Brandenburg Capital and 9 others have invested in rounds before Springboard Health Angels. There is 1 company where i&i Bio has invested before Springboard Health Angels and 1 company where Brandenburg Capital has invested before Springboard Health Angels.
- Top Co-investors of Springboard Health Angels: 25 investors entered a company along with Springboard Health Angels. These include investors like Pace Ventures (2 companies).
- Invested after Springboard Health Angels: A total of 5 investors have invested in Springboard Health Angels's portfolio after their investments. Top Investors include Companisto (1 company) and Freigeist Capital (1 company).
Recent News related to Springboard Health Angels
•
Captain T Cell Concludes Financing Round to Advance Next-Generation TCR-T Cell TherapyBakersfield•Nov 17, 2025•Captain T Cell, Springboard Health Angels, PLUTON, i&i Bio and 2 others
•
Avallon Raises $4.6M in Seed FundingFinSMEs•Nov 06, 2025•Avallon, Booom, 1984 Ventures, Y Combinator and 13 others
•
Novoflow, founded by a college dropout, raises $3.1 million in funding for its medical AI.Wowtale•Nov 04, 2025•Novoflow, Y Combinator, Saras Capital, Cellbyte and 3 others
•
CGC Genomics Secures €1.7 Million in Pre-Seed Funding for Cancer Diagnosis AIStartup Rise EU•Apr 14, 2025•CANCER GENOMICS CONSORTIUM, Heal Capital, Becker Ventures, Springboard Health Angels and 2 others
